Bret Jensen

|RSS

Currently the editor of "The Biotech Forum," Bret Jensen was chief investment strategist for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami, from 2008-2011. The fund was in the top 5% of long/short hedge funds for total return in its first full year (2009), as ranked by Hedgeco fund database (more than 450 funds in category). Prior to this, he spent a decade as technology director of a Fortune 100 firm.Expand

Jensen has been a top-5%-ranked financial analyst and blogger since 2013, according to TipRanks. He holds a Bachelor of Science degree in finance from Arizona State University.

Follow Bret on Twitter: @Bret_Jensen.Collapse

By

Bret Jensen

 | Apr 27, 2016 | 8:48 AM EDT
Futures hanging in there well given disappointing numbers from Apple (AAPL) which is down some 8% in pre-market trading at this point. Helping is oil...
By

Bret Jensen

 | Apr 26, 2016 | 1:11 PM EDT
Market pretty flat at mid-day. Biotech weak today probably due to some profit taking and some high profile disappointments in sector today....
By

Bret Jensen

 | Apr 26, 2016 | 11:00 AM EDT

Investing in small-cap names take a lot of research and patience, but they can also be very rewarding.

By

Bret Jensen

 | Apr 26, 2016 | 9:35 AM EDT
Market open flat despite some slightly disappointing economic readings. Durable Goods come in slightly lower than expected. Home prices also...
By

Bret Jensen

 | Apr 25, 2016 | 12:52 PM EDT
Markets down about half a percent across the board to start the trading week. Perrigo Group (PRGO) major hit due to guidance and CEO's pending...
By

Bret Jensen

 | Apr 25, 2016 | 12:00 PM EDT

This stock is undervalued and has good products in the pipeline.

By

Bret Jensen

 | Apr 22, 2016 | 12:54 PM EDT
Markets down slightly across the board except for the NASDAQ where major movers after disappointing results in heavyweights Alphabet (GOOGL),...
By

Bret Jensen

 | Apr 22, 2016 | 9:55 AM EDT
Market opens mixed as earnings reports flood in. Biotech again outperforming after an almost three percent rise in a down market yesterday. Some...
By

Bret Jensen

 | Apr 22, 2016 | 9:00 AM EDT

There are lots of winners in the first quarter.

By

Bret Jensen

 | Apr 21, 2016 | 1:41 PM EDT
Biotech having a big day in a relatively flat market as the main indices are up north of a little over 2% Relypsa (RLYP) up 15% on some more vague...

BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.